Concourse Financial Group Securities’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-9,580
| Closed | -$5.5M | – | 7657 |
|
2024
Q4 | $5.5M | Sell |
9,580
-442
| -4% | -$254K | 0.31% | 74 |
|
2024
Q3 | $6.2M | Sell |
10,022
-625
| -6% | -$387K | 0.37% | 54 |
|
2024
Q2 | $5.89M | Sell |
10,647
-45
| -0.4% | -$24.9K | 0.37% | 58 |
|
2024
Q1 | $6.22M | Buy |
10,692
+86
| +0.8% | +$50K | 0.4% | 51 |
|
2023
Q4 | $5.63M | Sell |
10,606
-734
| -6% | -$390K | 0.4% | 51 |
|
2023
Q3 | $5.74M | Buy |
11,340
+154
| +1% | +$78K | 0.45% | 43 |
|
2023
Q2 | $5.84M | Buy |
11,186
+498
| +5% | +$260K | 0.44% | 45 |
|
2023
Q1 | $6.16M | Sell |
10,688
-260
| -2% | -$150K | 0.48% | 39 |
|
2022
Q4 | $6.03M | Buy |
10,948
+87
| +0.8% | +$47.9K | 0.49% | 37 |
|
2022
Q3 | $5.51M | Sell |
10,861
-166
| -2% | -$84.2K | 0.52% | 28 |
|
2022
Q2 | $5.99M | Sell |
11,027
-786
| -7% | -$427K | 0.51% | 34 |
|
2022
Q1 | $6.98M | Sell |
11,813
-508
| -4% | -$300K | 0.51% | 33 |
|
2021
Q4 | $8.22M | Buy |
12,321
+677
| +6% | +$452K | 0.47% | 43 |
|
2021
Q3 | $6.66M | Sell |
11,644
-243
| -2% | -$139K | 0.41% | 52 |
|
2021
Q2 | $6M | Buy |
11,887
+1,486
| +14% | +$750K | 0.38% | 56 |
|
2021
Q1 | $4.75M | Buy |
10,401
+188
| +2% | +$85.8K | 0.33% | 65 |
|
2020
Q4 | $4.76M | Buy |
10,213
+491
| +5% | +$229K | 0.36% | 57 |
|
2020
Q3 | $4.3M | Buy |
9,722
+104
| +1% | +$45.9K | 0.37% | 56 |
|
2020
Q2 | $3.49M | Sell |
9,618
-400
| -4% | -$145K | 0.34% | 63 |
|
2020
Q1 | $2.84M | Buy |
10,018
+1,947
| +24% | +$553K | 0.31% | 69 |
|
2019
Q4 | $2.62M | Buy |
8,071
+5,919
| +275% | +$1.92M | 0.26% | 82 |
|
2019
Q3 | $627K | Sell |
2,152
-5,811
| -73% | -$1.69M | 0.16% | 111 |
|
2019
Q2 | $2.34M | Buy |
7,963
+641
| +9% | +$188K | 0.24% | 79 |
|
2019
Q1 | $2M | Sell |
7,322
-432
| -6% | -$118K | 0.21% | 90 |
|
2018
Q4 | $1.74M | Buy |
7,754
+3,746
| +93% | +$839K | 0.21% | 94 |
|
2018
Q3 | $979K | Buy |
+4,008
| New | +$979K | 0.28% | 80 |
|